Jacksonville, FL

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Neoplasms 82%
3. Breast Neoplasms 64%
4. Therapeutics 56%
5. Mutation 52%
6. Brain 51%
7. Genes 46%
8. Amyloid 43%
9. Survival 43%
10. Stroke 38%
11. Frontotemporal Dementia 38%
12. Liver Transplantation 37%
13. Pathology 36%
14. Synucleins 36%
15. Proteins 34%
16. Frontotemporal Lobar Degeneration 29%
17. Dementia 29%
18. Parkinsonian Disorders 26%
19. Amyotrophic Lateral Sclerosis 26%
20. Progressive Supranuclear Palsy 25%
21. Confidence Intervals 24%
22. Transplants 23%
23. Population 22%
24. Tauopathies 22%
25. Drug Therapy 22%
26. Amyloid beta-Protein Precursor 22%
27. Multiple Myeloma 21%
28. Phenotype 21%
29. Glioblastoma 21%
30. Biomarkers 21%
31. Pancreatic Neoplasms 21%
32. Meta-Analysis 21%
33. Neurodegenerative Diseases 20%
34. Radiotherapy 20%
35. Breast 19%
36. Safety 19%
37. Apolipoproteins E 19%
38. Cognitive Dysfunction 19%
39. Mortality 18%
40. Biopsy 18%
41. Myocarditis 17%
42. Genome-Wide Association Study 17%
43. Neurons 17%
44. Recurrence 17%
45. Systematic Reviews 17%
46. Single Nucleotide Polymorphism 17%
47. Clinical Trials 16%
48. Odds Ratio 16%
49. Renal Cell Carcinoma 16%
50. Peptides 16%
51. Glioma 16%
52. Prostatic Neoplasms 16%
53. Adenocarcinoma 16%
54. Neoplasm Metastasis 15%
55. Incidence 15%
56. Transgenic Mice 15%
57. Liver 15%
58. Neurofibrillary Tangles 15%
59. Frontotemporal Dementia With Motor Neuron Disease 15%
60. Barrett Esophagus 15%
61. Progranulins 15%
62. Lewy Bodies 14%
63. Brain Neoplasms 14%
64. Kidney 14%
65. Trastuzumab 14%
66. Amyloid Plaques 14%
67. Pharmaceutical Preparations 14%
68. Interstitial Cells of Cajal 14%
69. Protein Kinase C 14%
70. Atrophy 13%
71. Phosphotransferases 13%
72. Radiosurgery 13%
73. Growth 13%
74. Antibodies 13%
75. Neuropathology 13%
76. Gastroparesis 13%
77. Acetylcholinesterase 13%
78. T-Lymphocytes 13%
79. Phosphorylation 13%
80. Alleles 13%
81. Lung 13%
82. Genome 13%
83. Transplant Recipients 13%
84. Neurotensin 12%
85. DNA 12%
86. Melanoma 12%
87. Progression-Free Survival 12%
88. In Vitro Techniques 12%
89. Serum 12%
90. Extracellular Vesicles 12%
91. Magnetic Resonance Imaging 12%
92. Placebos 12%
93. Gene Expression 11%
94. Cholangiocarcinoma 11%
95. RNA 11%
96. Stomach 11%
97. Guidelines 11%
98. Messenger RNA 11%